Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy-Reference-Cited by-同舟云学术

Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy

Published:2017-10-30 Issue:12 Volume:264 Page:2481-2486
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Bozovic Ivo,Kacar Aleksandra,Peric Stojan,Nikolic Ana,Bjelica Bogdan,Cobeljic Mina,Petrovic Milutin,Stojanov Aleksandar,Djuric Vanja,Stojanovic Miroslav,Djordjevic Gordana,Martic Vesna,Dominovic Aleksandra,Vukojevic Zoran,Basta Ivana

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/article/10.1007/s00415-017-8658-x/fulltext.html

Reference34 articles.

1. Van den Bergh PYK, Hadden RDM, Bouche P, Cornblath DR, Hahn A, Illa I et al (2010) European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripher. Eur J Neurol 17(3):356–363

2. Harbo T, Andersen H, Overgaard K, Jakobsen J (2008) Muscle performance relates to physical function and quality of life in long-term chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 13(3):208–217

3. Rajabally YA, Seri S, Cavanna AE (2016) Neuropsychiatric manifestations in inflammatory neuropathies: a systematic review. Muscle Nerve 54(1):1–8

4. Merkies ISJ, Kieseier BC (2016) Fatigue, pain, anxiety and depression in Guillain–Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Eur Neurol 75(3–4):199–206

5. Goebel A, Lecky B, Smith L-J, Lunn MP (2012) Pain intensity and distribution in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 46(2):294–295

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal models of immune-mediated demyelinating polyneuropathies;Autoimmunity;2024-06-08

2. Clinical characteristics in a cohort of patients with chronic inflammatory demyelinating polyneuropathy: a retrospective study;Revista Mexicana de Neurociencia;2024-06-04

3. Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain Related to Chronic Inflammatory Demyelinating Polyneuropathy: A Proof-of-Concept Study;Journal of Clinical Medicine;2024-05-09

4. Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy;BMC Neurology;2023-05-26

5. Prospective study of quality of life in patients with myotonic dystrophy type 2;Medicinska istrazivanja;2023